| Advances in oligonucleotide synthesis with technologies such as RNAi are creating new challenges.
GE Healthcare has developed the next generation ÄKTA™ oligopilot™ to meet them.
- ÄKTA oligopilot plus offers improved synthesis quality while reagent consumption and cycle times are reduced by more than 50% at small scale.
- Suitable for use at a very early stage of research, for molecular diagnostics and therapeutic applications such as RNAi.
- Enhanced UNICORN™ software configuration.
- New pump rinsing system and improved seal resistance reduce maintenance costs.
- Eight amidite sliders as standard. Excellent for RNA synthesis.
Order Numbers are kept the same.
An upgrade kit is available for upgrading the original ÄKTA oligopilot system.
|
ÄKTA oligopilot plus provides fully automated DNA/RNA oligonucleotide synthesis in research and process development.
Pumps are equipped with a rinsing system. The new pump inlet manifold has a reduced hold-up volume and improved fluid dynamics.
|
